Incycus Therapeutics Appoints Melissa Beelen as Vice President, Clinical Operations
03 avr. 2019 08h00 HE
|
Incysus Therapeutics, Inc.
NEW YORK, April 03, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
Physeon Positive Clinical Trial Results for its Veinplicity® Device to be Published in The Journal of Vascular Access
01 avr. 2019 09h00 HE
|
Physeon
SCHAFFHAUSEN, Switzerland, April 01, 2019 (GLOBE NEWSWIRE) -- Physeon GmbH, (“Physeon” or the “Company”), a leading developer of medical technology products for venous access, today announced that...
Axsome Therapeutics Receives FDA Breakthrough Therapy Designation for AXS-05 for the Treatment of Major Depressive Disorder
27 mars 2019 07h00 HE
|
Axsome Therapeutics, Inc.
Designation offers potential for expedited development and review NEW YORK, March 27, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company...
CURE Pharmaceutical Announces Completion of FDA Pre-IND Review and Clinical Trial Plans for CUREfilm Blue™ for Erectile Dysfunction
26 mars 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., March 26, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has successfully completed a pre-IND...
ExCellThera announces clearance by FDA and Health Canada for ECT-001 in new clinical trials in United States and Canada for the treatment of leukemia
25 mars 2019 08h07 HE
|
ExCellThera
MONTREAL, March 25, 2019 (GLOBE NEWSWIRE) -- ExCellThera Inc., a clinical stage biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for...
Update: CBD Unlimited Announces Completion of Product Label Review and Vendor Applications for Entrance into Pharmacy, Food, and Mass Retail
18 mars 2019 11h50 HE
|
CBD Unlimited, Inc.
CAVE CREEK, AZ, March 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Unlimited, Inc. formerly known as Endexx Corporation (EDXC), a provider of innovative phytonutrient-based food and...
Daxor Corporation to Present at the 31st Annual Roth Conference on March 19, 2019
15 mars 2019 08h30 HE
|
Daxor Corporation
NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Drug Development Outsourcing Outpaces Internal Spending but Remains Tactical and Reactive, According to Tufts Center for the Study of Drug Development
05 mars 2019 09h00 HE
|
Tufts Center for the Study of Drug Development
BOSTON, March 05, 2019 (GLOBE NEWSWIRE) -- Drug sponsors spend more on contract research organizations (CROs) to help develop new medicines than they do on internal staff and infrastructure, but...
Dr. William Chey Highlights Unmet Medical Need of Lactose Intolerance and Potential for Phase 3 Drug Candidate RP-G28 in Expert Call Hosted by Ritter Pharmaceuticals
28 févr. 2019 08h30 HE
|
Ritter Pharmaceuticals, Inc.
LOS ANGELES, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate...
NSF International to Provide Third-Party Certification of U.S. FDA Food Safety Requirements
25 févr. 2019 09h58 HE
|
NSF International
ANN ARBOR, Mich., Feb. 25, 2019 (GLOBE NEWSWIRE) -- NSF Certification, LLC, a wholly-owned subsidiary of global public health organization NSF International, is now accredited by the American...